Novel Method of Generating Linkage-Specific Diubiquitin Probes

Technology

Deubiquitinating enzymes (DUBs) are essential for many cellular pathways and have emerged as promising targets for pharmacological intervention. Deubiquitinating enzymes are the catalytic proteins responsible for cleaving target ubiquitin domains from proteins tagged to be degraded by one of many possible cellular processes. Activity-based probes (ABPs) have been widely used in profiling different classes of enzymes. In recent years, ABPs were also developed for DUBs. Although useful for profiling the most widely used probes provide no information on the chain linkage and target specificity of DUBs. This is because they lack a ubiquitin acceptor protein. Typically, DUBs interact with ubiquitin probes through their active site. The use of diubiquitin probes (diUbs) as opposed to monoubiquitin probes is favored because the presence of an ubiquitin acceptor protein allows researchers to determine chain linkage- and target-specificity of DUBs.This particular invention mimics the native diUb in structure and size but differs by incorporating a Michael addition acceptor where the peptide bond would normally be located. The alkene acceptor can “trap” the DUB for improved specificity labeling and subsequent understanding of cellular processes.This class of DUB probes will also facilitate the development of more specific inhibitors againstthe large number of DUBs that are expected to possess chain or target specificities This technology can also be applied to generate probes based on ubiquitinated proteins such as PCNA, histone, α-synuclein and many other human proteins.Moreover, availability of this class of DUB probes will also facilitate the development of more specific inhibitors against the large number of DUBs that are expected to possess chain or target specificities.

Benefits

  • Higher specificity of diUb probe for DUB
  • Improved method for understanding cellular processes involving DUBs
  • Simple chemical manufacturing process of probes
  • Potential for additional applications using other ubiquitinated proteins

Applications

  • Pharmaceutical companies investigating DUBs for pharmaceutical intervention.
  • Biotech companies that currently produce probes for DUBs.
  • Potential for additional applications using other ubiquitinated proteins.